View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 20, 2017

M&As this week: Nivalis Therapeutics, Medidata Solutions

Nautilus Merger Sub, a subsidiary of US-based pharmaceutical company, Nivalis Therapeutics, has reached a reverse takeover agreement to acquire Alpine Immune Sciences.

Nautilus Merger Sub, a subsidiary of US-based pharmaceutical company, Nivalis Therapeutics, has reached a reverse takeover agreement to acquire Alpine Immune Sciences.

Also based in the US, the target company is a biotechnology company.

Nivalis expects the acquisition to help accelerate development of novel immunotherapies in inflammation and immuno-oncology space.

"Medidata Solutions is set to acquire Mytrus, which will help the former to improve patient engagement by providing tools, data and insights for patients and researchers."

Medidata Solutions is set to acquire Mytrus, which will help the former to improve patient engagement by providing tools, data and insights for patients and researchers.

The acquirer company provides cloud-based solutions and data analytics for clinical research, while the target company is an e-clinical technology company.

Both companies involved in the acquisition are based in the US.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena